Women’s Digital Health Market Size, Share & Analysis Report, 2022-2030
The global Women’s Digital Health market gathered revenue around USD 2.9 billion in 2021 and market is set to grow USD 10.5 billion by the end of 2030 and is estimated to expand at a modest CAGR of 20.9% during the prediction period 2022 to 2030.
The rise in smartphone penetration, adoption of preventive healthcare, favorable regulations, and rise in funding are the factors propelling market growth and awareness. Around 50.0% of the world’s population is women and there were around one billion women in 2019 with a mobile device capable of using modern-day digital tools. Furthermore, the rising number of chronic and general illnesses and infectious diseases depicts the market potential for digital women’s healthcare. The conducive regulatory environment, enabling approval of the contemporary digital applications and devices catering to conventional women’s health issues, is further boosting the market growth.
The existing companies and new market players are focused on introducing innovative solutions in the market. In addition, the visible growth in funding and the startups is contributing to market growth. With over 200 startups worldwide offering around 3,000 digital women’s health solutions, the digital women’s healthcare ideas have received more than 1.0 billion in funding between 2015 to 2018.
The technological advancements in women’s healthcare have offered solutions to a wide range of women-related issues. The digital tools facilitate personalized and preventive care approaches at low cost and high accessibility. The advancing technology such as artificial intelligence and data science provide women with personalized insights by tracking their health indicators to make informed decisions regarding their health.
Report Scope of the Women’s Digital Health Market
|
Report Highlights |
Details |
|
Market Size By 2030 |
USD 10.5 Billion |
|
Growth Rate |
CAGR of 20.9% From 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Segments Covered |
|
|
Regional Scope |
|
|
Companies Mentioned |
HeraMED; iSono Health; Clue by Biowink; Chiaro Technology Ltd.; Natural Cycles; Ava Science, Inc.; NURX Inc.; Prima-Temp, Inc.; Glow; Lucina Health; MobileODT Ltd., Braster SA; Athena Feminine Technologies; Plackal Tech. |
Type Insights
The mobile apps segment dominated the market and held the largest revenue share of 67.9% in 2021 owing to the rising adoption of mobile apps for the management of menstrual cycles, fertility cycles, and pregnancy. On the other hand, the wearable device segment is likely to witness the fastest growth over the forecast period and the diagnostics tools are also gaining attention gradually with new developments introduced by the companies.
The adoption of these digital tools is rapidly growing owing to the convenience and accessibility of the tools. The continuous technological advancements in the field of digital health allow women to be updated about their health status and make informed decisions based on actionable insights.
Application Insights
The reproductive health segment dominated the market and accounted for the largest revenue share of 43.0% in 2021 pertaining to the highest adoption rate of mobile applications catering to female health care management. On the other hand, the general healthcare and wellness segment is likely to witness the fastest growth over the forecast period.
The market is gradually opening up to cater to additional women’s issues such as pelvic care, pregnancy care, and chronic illnesses such as breast cancer and cervical cancer. The notable advances such as at-home screening help in the early detection of cancer, the pregnancy monitoring platforms help in self-monitoring of required health indications, and analytics platforms help in identifying women at the risk of preterm birth or other complications.
Regional Insights
In 2021, North America dominated the market and accounted for the largest revenue share of 43.1%. This is owing to the availability of advanced technological infrastructure, better access to the latest devices, better reach for diagnosis and treatment, and higher disposable incomes. On the other hand, Asia Pacific is expected to witness the fastest growth from 2022 to 2030. Emerging economies in this region, including China, India, and Singapore are exhibiting strong economic growth.
The government initiatives and favorable regulatory environment are further boosting the growth of the digital women’s healthcare market in these countries. In addition to the efforts to overcome the barrier concerning the socio-cultural approach towards women’s healthcare.
Some of the prominent players in the Women’s Digital Health Market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Women’s Digital Health Market Study:
Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Women’s Digital Health Market, By Type
7.1. Women’s Digital Health Market, By Type, 2020-2030
7.1.1. Mobile Apps
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Wearable Devices
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Diagnostic Tools
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Women’s Digital Health Market, By Application
8.1. Women’s Digital Health Market, by Application, 2020-2030
8.1.1. Reproductive Health
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pregnancy & Nursing Care
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Pelvic Care
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. General Healthcare & Wellness
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Women’s Digital Health Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Type (2017-2030)
9.1.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Type (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Type (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Type (2017-2030)
9.2.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Type (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Type (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Type (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Type (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Type (2017-2030)
9.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Type (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Type (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Type (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Type (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Type (2017-2030)
9.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Type (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Type (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Type (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Type (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Type (2017-2030)
9.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Type (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Type (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 10. Company Profiles
10.1. HeraMED
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. iSono Health
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Clue by Biowink
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Chiaro Technology Ltd.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Natural Cycles
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Ava Science, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. NURX Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Prima-Temp, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Glow
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Lucina Health
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. MobileODT Ltd.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Braster SA
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Athena Feminine Technologies
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
10.14. Plackal Tech
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers